SREBP1 regulates mitochondrial metabolism in oncogenic KRAS expressing NSCLC

Christian F Ruiz1, Emily D Montal2, John A Haley3

  • 1Department of Genetics, Yale University School of Medicine, New Haven, CT, USA.

Insights

Mutant KRAS in non-small cell lung cancer (NSCLC) upregulates the transcription factor SREBP1. SREBP1 knockdown inhibits cancer cell proliferation and impacts mitochondrial function, independent of lipogenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Metabolic Regulation

Background:

  • Cancer cells exhibit metabolic reprogramming to support malignant growth.
  • Mutant KRAS is a key oncogene influencing signaling pathways and tumor metabolism.
  • Oncogenic KRAS promotes de novo lipogenesis in non-small cell lung cancer (NSCLC).

Purpose of the Study:

  • To investigate the role of SREBP1 in KRAS-driven NSCLC metabolism.
  • To elucidate the mechanism by which KRAS influences SREBP1 expression and function.
  • To determine the impact of SREBP1 on cancer cell proliferation and mitochondrial activity.

Main Methods:

  • Genetic knockdown of SREBP1 in mutant KRAS-expressing NSCLC cells.
  • Carbon tracing studies to analyze metabolic pathways.
  • RNA sequencing (RNA-seq) to assess gene expression changes, particularly in mitochondrial components.

Main Results:

  • KRAS was found to increase SREBP1 expression.
  • SREBP1 knockdown significantly inhibited the proliferation of mutant KRAS NSCLC cells.
  • Unexpectedly, lipogenesis was not significantly altered by SREBP1 knockdown.
  • Carbon tracing revealed decreased oxidative phosphorylation.
  • RNA-seq data indicated reduced expression of mitochondrial electron transport chain (ETC) subunits.

Conclusions:

  • SREBP1 plays a crucial role in the proliferation of mutant KRAS NSCLC.
  • SREBP1 has a novel function in regulating mitochondrial function in this cancer model.
  • This function of SREBP1 is distinct from its known role in lipogenesis.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.9K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
3.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K